DUBIN THOMAS I H
Insider CIK 1231945 · INTS Director · NTBL Director · ALXN SVP and Chief Legal Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| INTS INTENSITY THERAPEUTICS, IN | A Award deriv | 2026-07-16 | 2026-07-20 | 5,500 | — | $0 | 5,500 | SEC↗ |
| INTS INTENSITY THERAPEUTICS, IN | A Award deriv | 2025-05-02 | 2025-05-06 | 50,000 | — | $0 | 50,000 | SEC↗ |
| INTS INTENSITY THERAPEUTICS, IN | A Award deriv | 2024-05-14 | 2024-05-15 | 50,000 | — | $0 | 50,000 | SEC↗ |
| NTBL Notable Labs, Ltd. | A Award | 2024-05-08 | 2024-05-10 | 40,247 | — | $0 | 40,247 | SEC↗ |
| NTBL Notable Labs, Ltd. | A Award deriv | 2024-01-24 | 2024-01-26 | 9,753 | — | $0 | 9,753 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-08-23 | 2012-08-27 | 24,328 | $103.09 | $2.51M | 74,905 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-08-23 | 2012-08-27 | 9,200 | $103.87 | $955.6K | 65,705 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-31 | 2012-07-31 | 680 | $104.94 | $71.4K | 99,233 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 4,000 | — | $0 | 60,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 82,671 | — | $0 | 12,751 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 56,250 | — | $0 | 43,750 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-07-27 | 2012-07-31 | 28,124 | — | $0 | 61,876 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 6,268 | $105.76 | $662.9K | 265,358 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 4,000 | $78.88 | $315.5K | 271,626 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 28,124 | $42.66 | $1.20M | 267,626 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 82,671 | $17.98 | $1.49M | 183,252 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 16,642 | $106.35 | $1.77M | 248,716 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 51,303 | $107.57 | $5.52M | 197,413 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 68,632 | $108.56 | $7.45M | 128,781 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 28,200 | $109.28 | $3.08M | 100,581 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-07-27 | 2012-07-31 | 668 | $106.14 | $70.9K | 99,913 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-07-27 | 2012-07-31 | 56,250 | $22.90 | $1.29M | 239,502 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-06-15 | 2012-06-19 | 36,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-06-15 | 2012-06-19 | 6,578 | — | $0 | 95,422 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-06-15 | 2012-06-19 | 36,000 | $17.65 | $635.4K | 136,581 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-06-15 | 2012-06-19 | 6,578 | $17.98 | $118.3K | 143,159 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-06-15 | 2012-06-19 | 9,011 | $94.04 | $847.4K | 100,581 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-06-15 | 2012-06-19 | 33,567 | $93.96 | $3.15M | 109,591 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-29 | 2012-05-31 | 20,092 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-29 | 2012-05-31 | 39,000 | — | $0 | 36,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-29 | 2012-05-31 | 44,308 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-29 | 2012-05-31 | 39,000 | $17.65 | $688.4K | 203,981 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-29 | 2012-05-31 | 20,092 | $10.29 | $206.7K | 120,673 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-05-29 | 2012-05-31 | 103,400 | $92.02 | $9.51M | 100,581 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-29 | 2012-05-31 | 44,308 | $11.92 | $528.2K | 164,981 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-14 | 2012-05-14 | 18,088 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-14 | 2012-05-14 | 18,088 | $8.18 | $148.0K | 100,581 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-10 | 2012-05-14 | 5,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-10 | 2012-05-14 | 5,692 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-05-10 | 2012-05-14 | 9,908 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-10 | 2012-05-14 | 5,000 | $17.65 | $88.3K | 82,493 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-10 | 2012-05-14 | 5,692 | $11.92 | $67.8K | 77,493 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-05-10 | 2012-05-14 | 9,908 | $10.29 | $102.0K | 71,931 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-03-14 | 2012-03-16 | 20,000 | — | $0 | 20,092 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-03-14 | 2012-03-16 | 21,912 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-03-14 | 2012-03-16 | 24,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-03-14 | 2012-03-16 | 20,000 | $10.29 | $205.8K | 127,935 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-03-14 | 2012-03-16 | 21,912 | $8.18 | $179.2K | 107,935 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-03-14 | 2012-03-16 | 11,200 | $89.24 | $999.5K | 62,023 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-03-14 | 2012-03-16 | 54,712 | $88.72 | $4.85M | 73,233 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-03-14 | 2012-03-16 | 24,000 | $6.90 | $165.6K | 86,023 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-22 | 2012-02-23 | 32,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-22 | 2012-02-23 | 40,000 | — | $0 | 0 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-22 | 2012-02-23 | 32,000 | $5.18 | $165.8K | 151,894 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-22 | 2012-02-23 | 40,000 | $5.10 | $204.0K | 119,894 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-22 | 2012-02-23 | 84,871 | $83.45 | $7.08M | 67,023 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-02-22 | 2012-02-23 | 5,000 | $83.84 | $419.2K | 62,023 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise deriv | 2012-02-03 | 2012-02-06 | 64,000 | — | $0 | 64,000 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | M Exercise | 2012-02-03 | 2012-02-06 | 8,000 | — | $0 | 79,894 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-30 | 2012-01-30 | 2,002 | $74.51 | $149.2K | 71,894 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-27 | 2012-01-30 | 663 | $74.41 | $49.3K | 73,896 | SEC↗ |
| ALXN ALEXION PHARMACEUTICALS IN | S Sale | 2012-01-10 | 2012-01-11 | 562 | $75.00 | $42.1K | 74,559 | SEC↗ |